Sponsor or institution
Clinical trials and research at Ikaria Bioscience Pty Ltd
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Ikaria Bioscience Pty Ltd that are recruiting, in Australia. By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
RN5681 dosing and safety in healthy adults with elevated LDL and Lp(a)
This trial will test single doses of RN5681 versus placebo to see if the drug is safe, how the body handles it, and how it changes LDL-C and Lp(a) in healthy adults with elevated levels.
-
Phase 1/2a: RN3161 alone and with tirzepatide for safety, how the drug works in the body, and effects on weight in adults with overweight or obesity
This trial will test RN3161 by itself in healthy volunteers and RN3161 with tirzepatide in adults with overweight or obesity to see if it is safe and changes body weight.
Quick answers
How many clinical trials run by Ikaria Bioscience Pty Ltd are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Australia. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.